Is it too late for me to buy this unstoppable FTSE 250 stock?

This FTSE 250 stock has rewarded investors well in the past few years. But is it too pricey to buy now or will it rise further?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Senior Man Sitting On Sofa At Home With Pet Labrador Dog

Image source: Getty Images

Animal medicine provider Dechra Pharmaceuticals (LSE: DPH) made an impressive statement in its trading update today. The company now expects stronger than expected trading performance” for its full financial year that ended on June 30. 

In itself, the statement is positive enough. But what I found truly impressive was that this update comes just a little over a month after its last one. It expects revenue growth of 21% in the past year, with robust growth in both Europe and North America. This performance follows consistent revenue increases over the past few years. 

5 Stocks For Trying To Build Wealth After 50

One notable billionaire made 99% of his current wealth after his 50th birthday. And here at The Motley Fool, we believe it is NEVER too late to start trying to build your fortune in the stock market. Our expert Motley Fool analyst team have shortlisted 5 companies that they believe could be a great fit for investors aged 50+ trying to build long-term, diversified portfolios.

Click here to claim your free copy now!

Robust share price rise, but pricey too

It is little surprise then, that the FTSE 250 stock has seen an impressive increase over the years. In the past five years, it has shown a 284% increase in share price. In the past year alone its share price is up over 57%. And today, its share price is up another 1% after its update. 

Much as I would like to buy this unstoppable stock now, I am hesitant after looking at its price-to-earnings (P/E) ratio, which is at a whole 111 times right now. It is likely that it will decline once detailed earnings numbers for the full year become available. Its forward P/E is estimated to be 40 times, which is significantly lower than it is now. However, in comparison to many other high potential FTSE 100 and FTSE 250 stocks, it is still quite high. 

What’s next for Dechra Pharmaceuticals

I can still justify buying the share at an elevated P/E if it has great growth prospects. I am not sure that will be the case next year, compared to the robust trend seen this year. The past year was particularly good for Dechra Pharmaceuticals as people have spent more time with their pets in the lockdown. As a result, the company points out, they could have become more aware of their healthcare needs. It is also possible that pet ownership has increased in its target markets. In the UK alone, 3.2m households have acquired a pet in the last 16 months. 

Now, however, there is already anecdotal evidence of people returning their pandemic pets to shelters. This indicates that the next year may not be as positive. 

What I would do now about the FTSE 250 stock

Keeping this in mind, I am willing to wait longer before making a decision on buying the stock. It releases its results in September, which will answer two questions for me. 

One, what its outlook is for the next year. A continued positive outlook would build the case to buy it. In any case the medium to long-term outlook for the pet industry is decent. But knowing that it will continue to grow even after the pandemic spurt, will give me greater confidence in the stock. And two, what its P/E looks like after the earnings update. This will tell me how expensive it is compared to other stocks for a fact. 

For now, it is a wait and watch for me.

Is this little-known company the next ‘Monster’ IPO?

Right now, this ‘screaming BUY’ stock is trading at a steep discount from its IPO price, but it looks like the sky is the limit in the years ahead.

Because this North American company is the clear leader in its field which is estimated to be worth US$261 BILLION by 2025.

The Motley Fool UK analyst team has just published a comprehensive report that shows you exactly why we believe it has so much upside potential.

But I warn you, you’ll need to act quickly, given how fast this ‘Monster IPO’ is already moving.

Click here to see how you can get a copy of this report for yourself today

Manika Premsingh has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Renewable energies concept collage
Investing Articles

What’s going on with the SSE share price?

Jon Smith goes through SSE's full-year results and talk of a windfall tax to see how the news is impacting…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

My top growth stocks to buy before June!

Growth stocks, generally, have performed very poorly this year. But amid continued volatility, these are my top picks to help…

Read more »

Playful senior couple in aprons dancing and smiling while preparing healthy dinner at home
Investing Articles

Is the Amigo share price back from the dead?

The Amigo share price is up by double-digits this week after the firm made an exciting announcement. Zaven Boyrazian investigates.

Read more »

Burst your bubble thumbtack and balloon background
Investing Articles

After plunging 40%, is Snap stock a no-brainer buy? 

Snap stock fell around 40% yesterday, due to an update saying it would miss Q2 revenue and profit expectations. Is…

Read more »

Investing Articles

Why growth stocks will continue to fall

With central banks around the world fretting over inflation, and the UK likely to enter a recession, I think growth…

Read more »

Passive income text with pin graph chart on business table
Investing Articles

How I’d use £10 a week to earn passive income for life

Dividend shares are an excellent way to earn passive income. Our writer considers how starting small but early could reap…

Read more »

Happy retired couple on a yacht
Investing Articles

I’m listening to SIPP millionaires to improve my returns

How do pension millionaires choose their SIPP shares? Christopher Ruane looks at their approach and how it could help his…

Read more »

Hand holding pound notes
Investing Articles

Which would I buy now: BT or Vodafone shares?

BT and Vodafone shares have both risen in value over one year, but have been big losers over five years.…

Read more »